Insider Transactions in Q4 2020 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Ana K. Stankovic Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,221
+50.0%
|
-
|
|
Nov 23
2020
|
Stephen Christopher Linthwaite President & CEO |
SELL
Open market or private sale
|
Direct |
84,820
-36.85%
|
$508,920
$6.06 P/Share
|
|
Nov 20
2020
|
Colin Mc Cracken Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,699
-7.8%
|
$10,194
$6.28 P/Share
|
|
Nov 20
2020
|
Colin Mc Cracken Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,129
+8.97%
|
-
|
|
Nov 20
2020
|
Bradley Allen Kreger SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,854
-5.83%
|
$11,124
$6.28 P/Share
|
|
Nov 20
2020
|
Bradley Allen Kreger SVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,362
+8.07%
|
-
|
|
Nov 20
2020
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,300
-3.38%
|
$13,800
$6.28 P/Share
|
|
Nov 20
2020
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,651
+3.26%
|
-
|
|
Nov 20
2020
|
Stephen Christopher Linthwaite President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,791
-4.08%
|
$58,746
$6.28 P/Share
|
|
Nov 20
2020
|
Stephen Christopher Linthwaite President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,445
+2.7%
|
-
|